The following findings suggest the decision to defer initiation of ADT until clinical progression or at least 2 years after PSA relapse may be a safe approach that could considerably reduce costs...certainly not saying this would be the path I would go if other evidence of disease was found (scans, etc...)...but looks like a valid option for PSA rise only PC.
http://www.healio.com/hematology-oncology/prostate-cancer/news/online/%7B0b1602cb-2f7d-4bb6-8b9c-2566b49580a7%7D/immediate-adt-offers-little-os-benefit-for-psa-detected-prostate-cancer-relapse